NFKB1 and cancer: NF-κB is a well-established pro-inflammatory transcription factor that regulates numerous pathways and whose major role in inflammation, and, as a consequence, in cancer progression, metastasis, and drug resistance has been shown in many in vitro, pre-clinical, and clinical studies [19].